Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections

Annals of Internal Medicine

Volumn 135, Issue 1, 2001, Pages 41-50

  Gupta, K ^a   Hooton, T M ^a   Stamm, W E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFALEXIN; COTRIMOXAZOLE; FOSFOMYCIN; LEVOFLOXACIN; NITROFURANTOIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; DRUG EFFECT; ERADICATION THERAPY; HEALTH CARE ACCESS; HUMAN; INDWELLING CATHETER; PREVALENCE; PRIORITY JOURNAL; REVIEW; URINARY TRACT INFECTION; URINE CULTURE;

EID: 0035800029     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-1-200107030-00012     Document Type: Review

References (44)

1. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women
2. Diagnosis and treatment of uncomplicated urinary tract infection
3. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women
4. Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997
5. Antimicrobial resistance profiles among E. coli urinary tract isolates in the United States: A current view
6. Antimicrobial resistance among uropathogens causing community-acquired UTI in women: A nationwide analysis
7. A Canadian national surveillance study of urinary tract isolates from outpatients: Comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin
8. Multi-drug-resistant urinary tract isolates of Escherichia coli: Prevalence and patient demographics in the United States in 2000
9. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women
10. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: A randomized trial
11. Management of urinary tract infections in adults
12. Tables of antimicrobial agent pharmacology
13. Absence of bioactive metabolites of ampicillin and amoxycillin in man
14. Absorption and disposition kinetics of amoxicillin in normal human subjects
15. Pharmacokinetics and clinical use of cephalosporin antibiotics
16. Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole)
17. Comparative pharmacodynamics, urinary excretion, and half-life determinations of nitrofurantoin sodium
18. Fusfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections
19. Clinical pharmacokinetics of ciprofloxacin
20. The clinical pharmacokinetics of levofloxacin
21. Continuing problems with the use of Augmentin for urinary tract infections
22. The antibiotic susceptibility patterns of uropathogens isolated from general practice patients in southern Netherlands
23. Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992
24. Comparative antimicrobial resistance and genomic diversity of Escherichia coli isolated from urinary tract infections in the community and in hospitals
25. Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991-1995
26. Which bacteria are found in Belgian women with uncomplicated urinary tract infections in primary health care, and what is their susceptibility pattern anno 95-96?
27. The changing patterns of antimicrobial susceptibility of urinary pathogens in Trinidad
28. Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Bangladesh
29. Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results
30. Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection
31. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women
32. Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice
33. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates
34. Factors associated with trimethoprim-resisrant bacteria isolated from urine samples
35. Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents
36. Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas
37. Intrafamilial spreading of Escherichia coli resistant to trimethoprim
38. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women
39. Trends in bacterial resistance to fluoroquinolones
40. Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli
41. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women
42. Fosfomycin for urinary tract infections
43. Single-dose amoxicillin therapy for urinary tract infection. Multicenter trial using antibody-coated bacteria localization technique